First translational ‘Think Tank’ on cerebrovascular disease, cognitive impairment and dementia
Barone, Frank C.
Crystal, Howard A.
Adamski, Mateusz G.
Baird, Alison E.
Brickman, Adam M.
Biessels, Geert Jan
Sorond, Farzaneh A.
Zhang, Zheng GangNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationBarone, F. C., D. Gustafson, H. A. Crystal, H. Moreno, M. G. Adamski, K. Arai, A. E. Baird, et al. 2016. “First translational ‘Think Tank’ on cerebrovascular disease, cognitive impairment and dementia.” Journal of Translational Medicine 14 (1): 50. doi:10.1186/s12967-016-0806-z. http://dx.doi.org/10.1186/s12967-016-0806-z.
AbstractAbstract and introduction to the workshop As the human population continues to age, an increasing number of people will exhibit significant deficits in cognitive function and dementia. It is now recognized that cerebrovascular, metabolic and neurodegenerative diseases all play major roles in the evolution of cognitive impairment and dementia. Thus with our more recent recognition of these relationships and our need to understand and more positively impact on this world health problem, “The Leo and Anne Albert Charitable Trust” (Gene Pranzo, Trustee with significant support from Susan Brogan, Meeting Planner) provided generous support for this inaugural international workshop that was held from April 13–16, 2015 at the beautiful Ritz Carlton Golf Resort in North Naples, Florida. Researchers from SUNY Downstate Medical Center, Brooklyn, NY organized the event by selecting the present group of translationally inclined preclinical, clinical and population scientists focused on cerebrovascular disease (CVD) risk and its progression to vascular cognitive impairment (VCI) and dementia. Participants at the workshop addressed important issues related to aging, cognition and dementia by: (1) sharing new data, information and perspectives that intersect vascular, metabolic and neurodegenerative diseases, (2) discussing gaps in translating population risk, clinical and preclinical information to the progression of cognitive loss, and (3) debating new approaches and methods to fill these gaps that can translate into future therapeutic interventions. Participants agreed on topics for group discussion prior to the meeting and focused on specific translational goals that included promoting better understanding of dementia mechanisms, the identification of potential therapeutic targets for intervention, and discussed/debated the potential utility of diagnostic/prognostic markers. Below summarizes the new data-presentations, concepts, novel directions and specific discussion topics addressed by this international translational team at our “First Leo and Anne Albert Charitable Trust ‘Think Tank’ VCI workshop”.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:25658397
- HMS Scholarly Articles